BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30312482)

  • 1. The efficacy of extracorporeal photopheresis to arrest bronchiolitis obliterans in lung allograft recipients was compared between two automated photopheresis instruments.
    Chionis L; Grossman BJ; Hachem R; Commean P; Derfler MC; Vedantham S; Dodds K; Spitznagel E; Atkinson J; Despotis G
    Transfusion; 2018 Dec; 58(12):2933-2941. PubMed ID: 30312482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of iron deficiency anemia in patients undergoing extracorporeal photopheresis: Comparison of the UVAR and CELLEX instruments.
    Moosavi MM; Goodman AL; Duncan A; Stowell SR; Waller EK; Roback JD; Sullivan HC
    J Clin Apher; 2021 Feb; 36(1):34-40. PubMed ID: 32894888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linear relationship between lymphocyte counts in peripheral blood and buffy coat collected during extracorporeal photopheresis.
    Liu C; Shah K; Dynis M; Eby CS; Grossman BJ
    Transfusion; 2013 Nov; 53(11):2635-43. PubMed ID: 23414109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal photopheresis performed on the CELLEX® compared with the UVAR-XTS® instrument is more efficient and better tolerated in children with steroid-refractory graft-versus-host disease.
    Kapadia E; Wong E; Perez-Albuerne E; Jacobsohn D
    Pediatr Blood Cancer; 2015 Aug; 62(8):1485-8. PubMed ID: 25881179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CELLEX is comparable to the UVAR-XTS for the treatment of acute and chronic graft versus host disease (GVHD).
    Afzal A; Tarbunova M; Despotis G; Grossman BJ
    Transfusion; 2020 Feb; 60(2):351-357. PubMed ID: 31919871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Associated With Mortality and Response to Extracorporeal Photopheresis in Lung Allograft Recipients With Bronchiolitis Obliterans Syndrome.
    Karnes HE; Schindler EI; Morrell M; Hachem RR; Berman K; Vedantham S; Atkinson J; Spitznagel E; Despotis GJ
    Transplantation; 2019 May; 103(5):1036-1042. PubMed ID: 30130331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the CELLEX™ and UVAR-XTS™ closed-system extracorporeal photopheresis devices in the treatment of chronic graft-versus-host disease.
    Whittle RM; Denney H; Chantry AD; Alfred A; Taylor PC
    J Clin Apher; 2017 Dec; 32(6):462-473. PubMed ID: 28608529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction.
    ; Hage CA; Klesney-Tait J; Wille K; Arcasoy S; Yung G; Hertz M; Chan KM; Morrell M; Goldberg H; Vedantham S; Derfler MC; Commean P; Berman K; Spitznagel E; Atkinson J; Despotis G
    Transfus Med; 2021 Aug; 31(4):292-302. PubMed ID: 33955079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal photopheresis for graft versus host disease: Identifying a clinical pathway and associated resource utilization.
    Yerrabothala S; Talebian L; Klinker K; Hickman J; Hill JM; Hayes C; Lowrey C; Szczepiorkowski ZM; Meehan KR
    J Clin Apher; 2018 Jun; 33(3):310-315. PubMed ID: 29193271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung transplant recipients on long-term extracorporeal photopheresis.
    Isenring B; Robinson C; Buergi U; Schuurmans MM; Kohler M; Huber LC; Benden C
    Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28653398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience.
    Benden C; Speich R; Hofbauer GF; Irani S; Eich-Wanger C; Russi EW; Weder W; Boehler A
    Transplantation; 2008 Dec; 86(11):1625-7. PubMed ID: 19077900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cessation of extracorporeal photopheresis in chronic lung allograft dysfunction: effects on clinical outcome in adults.
    Robinson CA; Huber L; Murer C; Schuurmans M; Kohler M; Hofbauer G; Benden C
    Swiss Med Wkly; 2017; 147():w14429. PubMed ID: 28488260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation.
    Jaksch P; Scheed A; Keplinger M; Ernst MB; Dani T; Just U; Nahavandi H; Klepetko W; Knobler R
    J Heart Lung Transplant; 2012 Sep; 31(9):950-7. PubMed ID: 22884382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation.
    Morrell MR; Despotis GJ; Lublin DM; Patterson GA; Trulock EP; Hachem RR
    J Heart Lung Transplant; 2010 Apr; 29(4):424-31. PubMed ID: 19853479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
    Benden C; Haughton M; Leonard S; Huber LC
    J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Off-Line Extracorporeal Photochemotherapy in Patients with Chronic Lung Allograft Rejection Not Responsive to Conventional Treatment: A 10-Year Single-Centre Analysis.
    Del Fante C; Scudeller L; Oggionni T; Viarengo G; Cemmi F; Morosini M; Cascina A; Meloni F; Perotti C
    Respiration; 2015; 90(2):118-28. PubMed ID: 26112178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early extracorporeal photopheresis treatment is associated with better survival in patients with chronic or recurrent acute lung allograft dysfunction.
    Gautschi F; Vogelmann T; Ortmanns G; Knörr F; Steinack C; Hage R; Nägeli M; Schuurmans MM
    J Clin Apher; 2024 Jun; 39(3):e22128. PubMed ID: 38829041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions.
    Hefazi M; Langer KJ; Khera N; Adamski J; Roy V; Winters JL; Gastineau DA; Jacob EK; Kreuter JD; Gandhi MJ; Hogan WJ; Litzow MR; Hashmi SK; Yadav H; Iyer VN; Scott JP; Wylam ME; Cartin-Ceba R; Patnaik MM
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1906-1913. PubMed ID: 29679771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD209
    Ni X; Austin M; Langridge T; Bojaxhi P; Bijani P; Wang X; Duvic M
    Photodermatol Photoimmunol Photomed; 2020 Jul; 36(4):290-298. PubMed ID: 32187738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation.
    Brownback KR; Simpson SQ; Pitts LR; Polineni D; McGuirk JP; Ganguly S; Aljitawi OS; Lin TL; Singh A; Abhyankar S
    J Clin Apher; 2016 Aug; 31(4):347-52. PubMed ID: 26031713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.